Crossmark

Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

Crossref DOI link: https://doi.org/10.1007/s40266-020-00744-3

Published Online: 2020-02-04

Published Print: 2020-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Porcari, Serena

Viola, Anna

Orlando, Ambrogio

Privitera, Antonino Carlo

Ferracane, Concetta

Cappello, Maria

Vitello, Alessandro

Siringo, Sebastiano

Inserra, Gaetano

Magnano, Antonio

Mocciaro, Filippo

Di Mitri, Roberto

Belluardo, Nunzio

Fidanza, Oriana

Garufi, Serena

Magrì, Giovanni

Bertolami, Carmelo

Carroccio, Antonio

Macaluso, Fabio Salvatore

Renna, Sara

Ventimiglia, Marco

Alibrandi, Angela

Cottone, Mario

Fries, Walter http://orcid.org/0000-0001-6159-7478
License Information

Text and Data Mining valid from 2020-02-04

Version of Record valid from 2020-02-04
More Information

Article History

First Online: 4 February 2020

Compliance with Ethical Standards

:

: The authors have no funding to declare for the present study.

: With regard to the content of the paper, the authors SP, AV, AO, ACP, CF, MC, AV, SS, GI, AM, FM, RDM, NB, OF, SG, GM, CB, Ac, FSM, SR, MV, AA, MC and WF have no conflicts of interest to declare.

: The study was approved by the Ethics Committee of the coordinating centre (protocol number 191/18).

Document is current

Any future updates will be listed below